Latest News
Sauce Labs, a provider of continuous test and remediation solutions that enable development teams to deliver high quality software at speed, has secured an additional strategic investment from TPG.
The deal provides Sauce Labs with additional resources and expertise to expand capabilities, further market leadership, and drive continued growth. TPG first invested in Sauce Labs in 2019, increasing its investment in 2021.
Sauce Labs enables enterprises to deliver high quality software at speed, providing a more seamless and secure experience for customers.
PHD Industrial Holdings – a North West-based conglomerate which acquires established SMEs – has appointed Richard Blackburn as group finance director.
Blackburn, who joins from leading architectural and engineering practice BDP, has 15 years’ experience in finance, having worked in accounting firms and held international roles in industry. He started his career with Mazars, where he qualified as a prize-winning chartered accountant and later worked in audit at Deloitte.
PHD Industrial Holdings, which brings together seven companies with a combined turnover in excess of £60 million and with over 330 employees, was previously known as PHD Equity Partners before changing
Northlane Capital Partners (NCP) has made an investment in SAI MedPartners (SAI), a consultancy providing strategic insights and analytics to the pharmaceutical, biotechnology, and medical device industries.
NCP invested in partnership with the SAI management team, led by Founder and CEO Erik Nordhoy.
Headquartered in Reading, Pennsylvania, SAI provides best-in-class competitive intelligence and strategy support services to assist its clients across the product development lifecycle.
Frazier Healthcare Partners (Frazier), a Seattle-based, healthcare-focused private equity firm, has completed its acquisition of Apollo Intelligence (Apollo), a provider of real-time data and insights to the healthcare and life science industries.
Frazier’s investment, experience, and deep industry knowledge will accelerate Apollo’s ambitious vision for the healthcare and life science spaces.
The Apollo platform launched with its acquisition of InCrowd, a pioneer of real-time, automated insights for the life science industry, as the founding company. In 2020, Apollo acquired Survey Healthcare Global, a global market leader of first-party healthcare data collection and custom survey solutions, to complement InCrowd and strengthen
EY is to make an investment of around $1 billion phased over four years to expand PE business capabilities and appoints Bridget Walsh as new EY Global Private Equity Leader, effective 1 July 2022, to lead and deliver this initiative.
The $1 billion investment bolsters the leading market position with a focus on growing existing transaction capabilities and expansion in the areas of value creation and portfolio transformation; deal leadership; and environment, social and governance (ESG) services. This goal will be supported by strategic acquisitions and by making key talent hires.
Walsh currently serves as EY EMEIA Managing Partner –
Investment manager Downing has agreed a £7.6 million funding facility to support Country Court, a UK operator and developer of elderly residential care.
The loan to develop a 69-bed modern purpose-built care home, is the start of a new relationship for Downing’s Development Capital team with Country Court – which owns and operates 35 homes in England.
The proportion of investors reporting net annual returns of over 16% across the lifetime of their private equity portfolios has reached near-record levels, according to Coller Capital’s latest Global Private Equity Barometer.
Some 42% of Limited Partners (LPs) now have portfolio-lifetime annual returns of over 16% net. This number has been exceeded only once since the Barometer was first published in 2004: in the Barometer of Summer 2007 in the run-up to the Global Financial Crisis (GFC).
Over 70% of LPs say their private equity assets have outperformed their public equity portfolios since the GFC. Indeed, most LPs say
Ariceum Therapeutics (Ariceum), a private biotech company developing a radiopharmaceutical product for the diagnosis and systemic targeted radiation therapy of certain hard-to-treat cancers, has completed an oversubscribed €25 million Series A financing round.
Ariceum was co-founded by EQT Life Sciences (formerly LSP) and HealthCap who also co-led the financing that was joined by Pureos Bioventures. Ipsen transferred assets, and all corresponding rights into the Company in late 2021.
The proceeds from the financing will enable Ariceum to further develop its lead asset and proprietary peptide derivative, satoreotide, a radiopharmaceutical drug and an antagonist of the somatostatin type 2 (SST2) receptor
Akin Gump has appointed Amy Wollensack and Sergio Urias, a pair of private equity transactional lawyers, as partners in the firm’s New York office.
Wollensack and Urias regularly advise on M&A, recapitalisations, leveraged buyouts, growth equity investments and related corporate transactions.
Urias’ practice also represents investment funds and strategic clients in Latin America.
The Access Group, a provider of business management software to mid-market organisations in the UK, Ireland and Asia Pacific, has secured further investment from its shareholders, Hg and TA Associates, with an associated enterprise value of £9.2 billion, believed to make it one of the largest UK headquartered software providers.
Access has grown significantly since its incorporation in 1991, delivering uninterrupted profitable growth in the last 15 years. Since 2020, Access has more than doubled in size driven by double-digit organic growth, combined with strategic M&A in the UK, Ireland and Asia Pacific. Access has grown its customer base to
Special Reports
Featured
- Insight
Events
12 November, 2026 – 8:00 am
12 November, 2026 – 5:00 pm
